Immunogenicity Associated with Aesthetic Botulinumtoxin A: A Survey of Asia-Pacific Physicians’ Experiences and Recommendations

BACKGROUND: Most botulinum toxin A (BoNT/A) products contain unnecessary bacterial components that increase the risk of developing neutralizing antibodies (nAbs). Reports of secondary nonresponse and treatment failures (STF) due to nAbs have accompanied a surge in new BoNT/A products. METHODS: To fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Je-Young, Corduff, Niamh, Frevert, Jürgen, Wanitphakdeedecha, Rungsima, Chao, Yates Y.Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Cosmetic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015201/
https://www.ncbi.nlm.nih.gov/pubmed/35450268
http://dx.doi.org/10.1097/GOX.0000000000004217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015201/
https://www.ncbi.nlm.nih.gov/pubmed/35450268
http://dx.doi.org/10.1097/GOX.0000000000004217

Ejemplares similares